Latest News for: calpain 2
Edit
Presentation at MNDA: Characterizing the CSF Biomarker Signature of Calpain-2 Activity in ALS and Its Application in the Phase 1 LUMINA Trial (dae63b) (Amylyx Pharmaceuticals Inc)
Public Technologies 05 Dec 2025
Characterizing the CSF Biomarker Signature of Calpain-2 Activity in ALS and Its Application in the Phase 1 ... Calpain-2 and Axonal Degeneration in ALS. Calpain-Driven Biomarkers ... Calpain-Driven Biomarkers ... Calpain-2 and Axonal Degeneration in ALS.
- 1